Background: Extracorporeal membrane oxygenation (ECMO) is not suitable for longterm support because of its high incidence of complications. Conversion from ECMO to ventricular assist device (VAD) is reasonable, and we have developed a simple algorithm for selecting proper VADs for these ECMO-supported patients. Methods: We converted 12 patients who were receiving ECMO support to VAD for bridge to transplantation. Group I (n = 6) was converted directly from ECMO to VAD. Group II (it = 6) underwent stage conversion. We added left atrial drainage to ECMO because of lung edema or marked left heart distension. We discontinued drainage after recovery of right heart function. Group II had more unfavorable risk factors for VAD before ECMO. Results:...
The survival of congenital heart disease (CHD) patients with single-ventricle (SV) physiology has ma...
OBJECTIVE: For patients in advanced heart failure, emergency transplantation or ventricular assist d...
Objective: To study the achievability of device weaning in patients receiving left ventricular assis...
Background. Extracorporeal membrane oxygenation (ECMO) provides an immediate support for acute deter...
The new allocation criteria classify patients on veno-arterial extracorporeal membranous oxygenation...
Background—The use of extracorporeal life support (extracorporeal membrane oxygenation [ECMO]) as a ...
AbstractObjective: Improving results with ventricular assist devices have led to their wider clinica...
Mechanical cardiac circulatory support has been established as a benefactory treatment modality for ...
Ventricular-assist devices (VADs) have benefitted patients with end-stage heart failure as a bridge ...
Introduction Peripheral veno-arterial extracorporeal membrane oxygenation (VA ECMO) is one of the mo...
Extracorporeal membrane oxygenation (ECMO) can rescue some critical patients with circulatory collap...
We developed a risk factor-scaling score (RFSS) to select which patients supported by extracorporeal...
BackgroundVenoarterial extracorporeal membrane oxygenation (VA ECMO) has been used for profound card...
In this retrospective study, the implant course and outcome of patients with ventricular assist devi...
Purpose: The left ventricular assist system (LVAS) is often used for end-stage heart failure. Howev...
The survival of congenital heart disease (CHD) patients with single-ventricle (SV) physiology has ma...
OBJECTIVE: For patients in advanced heart failure, emergency transplantation or ventricular assist d...
Objective: To study the achievability of device weaning in patients receiving left ventricular assis...
Background. Extracorporeal membrane oxygenation (ECMO) provides an immediate support for acute deter...
The new allocation criteria classify patients on veno-arterial extracorporeal membranous oxygenation...
Background—The use of extracorporeal life support (extracorporeal membrane oxygenation [ECMO]) as a ...
AbstractObjective: Improving results with ventricular assist devices have led to their wider clinica...
Mechanical cardiac circulatory support has been established as a benefactory treatment modality for ...
Ventricular-assist devices (VADs) have benefitted patients with end-stage heart failure as a bridge ...
Introduction Peripheral veno-arterial extracorporeal membrane oxygenation (VA ECMO) is one of the mo...
Extracorporeal membrane oxygenation (ECMO) can rescue some critical patients with circulatory collap...
We developed a risk factor-scaling score (RFSS) to select which patients supported by extracorporeal...
BackgroundVenoarterial extracorporeal membrane oxygenation (VA ECMO) has been used for profound card...
In this retrospective study, the implant course and outcome of patients with ventricular assist devi...
Purpose: The left ventricular assist system (LVAS) is often used for end-stage heart failure. Howev...
The survival of congenital heart disease (CHD) patients with single-ventricle (SV) physiology has ma...
OBJECTIVE: For patients in advanced heart failure, emergency transplantation or ventricular assist d...
Objective: To study the achievability of device weaning in patients receiving left ventricular assis...